ABSTRACT
Immune suppression plays critical roles in the development of chronic osteomyelitis, and the mechanisms underlying the development of immune suppression in chronic osteomyelitis have attracted much attention. LAG-3 is an important suppressor of T cell activation, but the role of LAG-3 in the immune regulation of chronic osteomyelitis is currently unknown. We sought to demonstrate if LAG-3 plays crucial roles in chronic osteomyelitis progression and has effects on immune suppression and exhausting of T cells, and what is the mechanism underlying LAG-3 deregulation in chronic osteomyelitis. We examined the expression of LAG-3 in the T cells of peripheral blood of 50 healthy controls and 50 patients with chronic osteomyelitis by flow cytometry. Clinical data were analyzed to determine the correlation between inflammation index and LAG-3 expression. Moreover, we isolated the CD4+ T cells from healthy controls and chronic osteomyelitis patients to compare cell proliferation and IFN-γ production. Chromatin immunoprecipitation assays were utilized to analyze the epigenetic modification on LAG-3 expression in T cells. We found that LAG-3 was significantly increased in the T cells of peripheral blood from chronic osteomyelitis patients. Subsequently, clinical data analysis suggested that the higher expression of LAG-3 was associated with severer inflammation situation. Consistently, LAG-3+CD4+ T cells exhibited impaired cell proliferation and IFN-γ secretion. Deregulation of histone methylation mediated the increase of LAG-3+ T cells during chronic osteomyelitis. Taken together, our study demonstrates the increase of LAG-3+ T cells and its immune regulatory roles in chronic osteomyelitis progression, suggesting new mechanisms and potential therapeutic targets for chronic osteomyelitis.
Similar content being viewed by others
REFERENCES
Blackburn, S.D., H. Shin, and W.N. Haining. 2009. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nature Immunology 10(1): 29–37.
Slenker, A.K., S.W. Keith, and D.L. Horn. 2012. Two hundred and eleven cases of Candida osteomyelitis: 17 case reports and a review of the literature. Diagnostic Microbiology and Infectious Disease 73(1): 89–93.
Rebecca, A.B., G.L. Jeff, H.C. Jason, C. William, and E.S. Mark. 2008. Osteomyelitis and the role of biofilms in chronic infection. FEMS Immunology and Medical Microbiology 52: 13–22.
Li, H., S. Hong, J. Qian, Y. Zheng, J. Yang, and Q. Yi. 2010. Cross talk between the bone and immune systems: osteoclasts function as antigen presenting cells and activate CD4+ and CD8+ T cells. Blood 116: 210–217.
Wagner, C., D. Heck, K. Lautenschlager, C. Iking-Konert, V. Heppert, A. Wentzensen, and G.M. Hansch. 2006. T lymphocytes in implant-associated posttraumatic osteomyelitis: identification of cytotoxic T effector cells at the site of infection. Shock 25(3): 241–246.
Kumar, G., P.M. Roger, M. Ticchioni, C. Trojani, R. Bernard de Dompsur, N. Bronsard, M. Carles, and E. Bernard. 2013. T cells from chronic bone infection show reduced proliferation and a high proportion of CD28−CD4+ T cells. Clinical and Experimental Immunology 176: 49–57.
Garlet, G.P., C.R. Cardoso, F.S. Mariano, M. Claudino, G.F. de Assis, A.P. Campanelli, M.J. Avila-Campos, and J.S. Silva. 2010. Regulatory T cells attenuate experimental periodontitis progression in mice. Journal of Clinical Periodontology 7: 591–600.
Wu, Y., Y. Tang, X. Liang, Y. Lin, W. Yang, Y. Ma, L. Huang, R. Yang, J. Ye, K. Chen, and H. Shen. 2011. The role of increased frequency of Treg cells in patients with chronic osteomyelitis. Orthopedics 34(2): 98–117.
Hogan, A., V.G. Heppert, and A.J. Suda. 2013. Osteomyelitis. Archives of Orthopaedic and Trauma Surgery 133(9): 1183–1196.
Li, F.-J., Y. Zhang, and G.-X. Jin. 2013. Expression of LAG-3 is coincident with the impaired effector function of HBV-specific CD8+ T cell in HCC patients. Immunology Letters 150(1–2): 116–122.
Okamura, T., K. Fujio, S. Sumitomo, and K. Yamamoto. 2012. Roles of LAG3 and EGR2 in regulatory T cells. Annals of the Rheumatic Diseases 71(supp): i96–i100.
Drake, C.G., E.J. Lipson, and J.R. Brahmer. 2014. Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer. Nature Reviews. Clinical Oncology 11(1): 24–37.
Gagliani, N., C.F. Magnani, and S. Huber. 2013. Coexpression of CD49b and LAG-3 human and mouse T regulatory type 1 cells. Nature Medicine 19(6): 739–746.
Grosso, J.F., M.V. Goldberg, D. Getnet, T.C. Bruno, H.R. Yen, K.J. Pyle, E. Hipkiss, D.A. Vignali, D.M. Pardoll, and C.G. Drake. 2009. Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells. The Journal of Immunology 82(11): 6659–6669.
Durham, N.M., C.J. Nirschl, C.M. Jackson, J. Elisa, C.M. Kochel, R.A. Anders, and C.G. Drake. 2014. Lymphocyte activation gene 3 (LAG-3) modulates the ability of CD4 T-cells to be suppressed in vivo. PLoS One 11(9): e109080.
Woo, S.R., M.E. Turnis, M.V. Goldberg, J. Bankoti, M. Selby, C.J. Nirschi, M.L. Bettini, D.M. Gravano, P. Vogel, C.L. Liu, S. Tangsombatvisit, J.F. Grosso, G. Netto, M.P. Smeltzer, A. Chaux, P.J. Utz, C.J. Workman, D.M. Pardoll, A.J. Korman, C.G. Drake, and D.A. Vignali. 2012. Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape. Cancer Research 72: 917–927.
Hou, J., Y. Zhou, Y.Y. Zheng, J. Fan, W. Zhou, I.O. Ng, H. Sun, L. Qin, S. Qiu, J.M. Lee, C.M. Lo, K. Man, Y. Yang, Y. Yang, Y. Yang, Q. Zhang, X. Zhu, N. Li, Z. Wang, G. Ding, S.M. Zhung, L. Zheng, X. Luo, Y. Xie, A. Liang, Z. Wang, M. Zhang, Q. Xia, T. Liang, Y. Yu, and X. Cao. 2014. Hepatic RIG-I predicts survival and interferon-α therapeutic response in hepatocellular carcinoma. Cancer Cell 25(1): 49–63.
Hiroshi, T. 2012. New developments in osteoimmunology. Nature Reviews. Rheumatology 8: 684–689.
Jorge, L.S., A.G. Chueire, and A.R. Rossit. 2010. Osteomyelitis: a current challenge. The Brazilian Journal of Infectious Diseases 14(3): 310–315.
Stucken, C., D.C. Olszewski, W.R. Creevy, A.M. Murakami, and P. Tornetta. 2013. Preoperative diagnosis of infection in patients with nonunions. Journal of Bone and Joint Surgery (American) 95: 1409–1412.
John, Werry E. 2011. T cells exhaustion. Nature Immunology 12: 492–499.
Linh, T.N., and S.O. Pamela. 2015. Clinical blockade of PD1 and LAG3—potential mechanisms of action. Nature Reviews Immunology 15: 45–56.
Workman, C.J., Y. Wang, K.C. El Kasmi, D.M. Pardoll, P.J. Murray, C.G. Drake, and D.A. Vignali. 2009. LAG-3 regulates plasmacytoid dendritic cell homeostasis. The Journal of Immunology 182: 1885–1891.
Workman, C.J., and D.A. Vignali. 2005. Negative regulation of T cell homeostasis by lymphocyte activation gene-3 (CD223). The Journal of Immunology 174: 688–695.
Okamura, K., S. Sumitomo, K. Morita, Y. Iwasaki, M. Inoune, S. Nakachi, T. Komai, H. Shoda, J. Miyazaki, K. Fujio, and K. Yamamoto. 2015. TGF-β3-expressing CD4+CD25−LAG3+ regulatory T cells control humoral immune responses. Nature Communications 6: 6329.
Matsuzaki, J., S. Gnjatic, P. Mhawech-Fauceglia, A. Beck, A. Miller, T. Tsuji, C. Eppolito, F. Qian, S. Lele, P. Shrikant, L.J. Old, and K. Odunsi. 2010. Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America 107: 7875–7880.
Richter, K., P. Agnellini, and A. Oxenius. 2010. On the role of the inhibitory receptor LAG3 in acute and chronic LCMV infection. International Immunology 22: 13–23.
Butler, N.S., J. Moebius, L.L. Pewe, B. Traore, O.K. Doumbo, L.T. Tygrett, T.J. Waldschmidt, P.D. Crompton, and J.T. Harty. 2012. Therapeutic blockade of PDL1 and LAG3 rapidly clears established blood-stage Plasmodium infection. Nature Immunology 13: 188–195.
ACKNOWLEDGEMENTS
The authors thank National Nature Science Foundation of China (Grant No. 81500290) for the financial support.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
Tao Chen has received research support funding from National Nature Science Foundation of China (Grant No. 81500290).
Additional information
Both Yicun Wang and Jun Wang have equal contributions and are co-first author.
Rights and permissions
About this article
Cite this article
Wang, Y., Wang, J., Meng, J. et al. Epigenetic Modification Mediates the Increase of LAG-3+ T Cells in Chronic Osteomyelitis. Inflammation 40, 414–421 (2017). https://doi.org/10.1007/s10753-016-0486-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-016-0486-0